<DOC>
	<DOCNO>NCT01802203</DOCNO>
	<brief_summary>To collect efficacy outcome data relate use trūFreeze® spray cryotherapy treatment unwanted tissue pulmonary gastrointestinal setting .</brief_summary>
	<brief_title>trūFreeze® Spray Cryotherapy Patient Registry</brief_title>
	<detailed_description>This prospective , multi-center registry patient currently undergo spray cryotherapy use trūFreeze® device . The registry population consist patient treat use spray cryotherapy trūFreeze® device removal unwanted tissue , malignant pre-malignant condition pulmonary gastrointestinal setting . Patients eligible participate registry disease treatment specific data collect throughout therapy long-term follow-up . Subjects consider complete registry data 5 year follow-up visit collect . The begin follow-up period commences first endoscopic treatment session . Subjects may withdraw prior follow reason : 1 . Death , 2 . Lost Follow-Up , 3 . Withdrawal consent , 4 . Discontinuation investigator . Three attempt contact use two different method require prior determination subject lose follow-up . Attempts contact must certify letter OR document telephone contact . The registry utilize electronic case report form use web-based platform house University North Carolina Chapel Hill . Access database limited individual involve research registry require unique user ID password . All access database web-based application encrypt ( HTTPS ) electronic system compliant applicable privacy security regulation . To maintain patient confidentiality , subject assign registry identification number , link subject identity treatment information . Read-only access provide personnel administrator responsible data entry . All data request case report form must record . All miss data must explain . The system allow sit directly enter data electronically , however sit still responsible ensure source document support data enter electronically separate verifiable . The registry system maintain audit trail capture electronic entry change , change , make change . The investigator ensure capability inspection applicable registry-related facility ( e.g . pharmacy , diagnostic laboratory , etc. ) . The registry monitor sponsor , allow audit Institutional Review Board , government regulatory body , University compliance quality assurance group registry related document ( e.g . source document , regulatory document , data collection instrument , registry data , etc . ) .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Constriction , Pathologic</mesh_term>
	<mesh_term>Barrett Esophagus</mesh_term>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Bronchial Neoplasms</mesh_term>
	<mesh_term>Esophageal Stenosis</mesh_term>
	<criteria>1 . GI condition include : Barrett 's Esophagus ( BE ) without dysplasia Squamous dysplasia Esophageal cancer , stage 2 . Pulmonary condition include : Any endobronchial cancerous precancerous disease locate within central airway Any nonmalignant endobronchial process central airway result abnormal mucosa ( i.e . granulation tissue , papillomatosis , sarcoidosis , tuberculosis , etc . ) Tracheal bronchial stenosis ( malignant benign ) Any pleural disease , malignant benign All subject require able provide write informed consent 1 . Gastrointestinal Exclusion Criteria Contraindication spray cryotherapy . Prior treatment spray cryotherapy . Previous concurrent treatment use mucosal therapy endoscopic mucosal resection radiofrequency ablation acceptable . Below 18 year age 2 . Pulmonary Exclusion Criteria Contraindication spray cryotherapy . Prior treatment spray cryotherapy . Previous concurrent treatment use mucosal therapy acceptable . Tracheoesophageal fistula . Bronchopleural fistula . Current untreated pneumothorax . Clinically significant hypoxia refractory supplemental oxygen therapy . Below 18 year age</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Barrett esophagus</keyword>
	<keyword>Esophageal dysplasia</keyword>
	<keyword>Upper gastrointestinal squamous dysplasia</keyword>
	<keyword>Esophageal cancer</keyword>
	<keyword>Endobronchial cancer</keyword>
	<keyword>Central airway cancer</keyword>
	<keyword>Central airway precancerous disease</keyword>
	<keyword>Central airway granulation tissue</keyword>
	<keyword>Central airway papillomatosis</keyword>
	<keyword>Central airway sarcoidosis</keyword>
	<keyword>Central airway tuberculosis</keyword>
	<keyword>Tracheal stenosis</keyword>
	<keyword>Bronchial stenosis</keyword>
</DOC>